NDC 68071-3695 – Emtricitabine and tenofovir disoproxil fumarate

Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC68071-3695

Product details

Brand name
Emtricitabine and tenofovir disoproxil fumarate
Generic name
Emtricitabine and tenofovir disoproxil fumarate
Labeler
NuCare Pharmaceuticals, Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA203442
Marketed since
March 9, 2022
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (1)

Package NDCDescriptionSince
68071-3695-33 TABLET, FILM COATED in 1 BOTTLE (68071-3695-3)Oct 4, 2024

Other Emtricitabine and tenofovir disoproxil fumarate products